People who have Down syndrome have a wide range of health problems because they age group.

Also, the usual diagnostic exams used for diagnosis of Alzheimer’s disease in people without Down syndrome usually do not look at the existing disabilities of the person with Down syndrome. Many people with Down syndrome cannot be evaluated by standard psychological tests. Finally, some people with Down syndrome have limited verbal and additional communication skills that may make assessment difficult. For these reasons, the methods used for testing for Alzheimer’s disease in people without Down syndrome are unreliable in people who have Down syndrome. Several clinical tools have been designed that are appropriate for diagnostic make use of in people who have Down syndrome.The study also discovered that while doctors are being among the most effective catalysts for advertising behavior change, only 20 percent of oncologists provide such guidance due to period constraints, competing treatment or health concerns, and uncertainty concerning the delivery of health behavior communications and their potential impact on a patient’s outcome. An accompanying editorial by Patricia A. Ganz, MD, of the Jonsson Comprehensive Cancer Middle at the University of California, Los Angeles, and co-chair of the ASCO Survivorship Task Force, mentioned that while a recent survey of ASCO members found that the majority of oncologists believe it is their function to provide ongoing health care, it isn’t yet apparent how focused that care is on surveillance for cancers recurrence versus health promotion, disease prevention, and monitoring or prevention lately effects.

Other articles from category "drugs":

Random articles